The HCPLive Allergy condition center page is a comprehensive resource for clinical news and insights on allergic and inflammatory diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for food and seasonal allergies, as well as allergic asthma and related conditions.
October 3rd 2024
Individuals with comorbid asthma and food allergies saw no loss of efficacy in this post hoc analysis, suggesting omalizumab’s potential for such patients.
September 17th 2024
Frequent Allergies in Pediatric Atopic Dermatitis, Eosinophilic Esophagitis Patients in Puerto Rico
New data presented at ACAAI 2022 observed various trends in allergies associated with eczema and eosinophilic esophagitis, comparing observed data with that of patients in the United States.
Dupilumab Shows Significant Efficacy for EoE in Pooled Analysis
Weekly dupilumab 300 mg versus placebo demonstrated statistically significant, clinically meaningful improvements in histologic and endoscopic outcomes and symptoms in adults and adolescents with eosinophilic esophagitis.
Study Identifies Pathogenic Cell States, Transcriptional Programs Specific to Asthma
May 18th 2022In particular, airway epithelial cells (AEC) in allergic asthmatic (AA) were shown to upregulate mucus metaplasia, matrix-remodeling, and glycolytic programs while failing to upregulate antioxidant genes.
Tolly Epstein, MD, MS: Post-Injection Monitoring and Epinephrine for Patients on Immunotherapy
February 25th 2022Dr. Epstein provides updates on a joint study between members of AAAAI and the American College of Allergy on the relationship between epinephrine and post-immunotherapy injection waiting periods.